SpringerLink
Log in

Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Locoregional recurrence (LRR) after mastectomy reduces the patient’s quality of life and survival. There is a consensus that postmastectomy radiotherapy (PMRT) helps establish locoregional control and reduces LRR in patients with ≥4 metastatic nodes. However, in patients with 1–3 metastatic nodes, the incidence of LRR and the role of PMRT have been the subject of substantial controversy. This study assessed the risk factors for LRR and the efficacy of PMRT in Japanese breast cancer patients with metastatic nodes.

Methods

This study analyzed 789 cases of invasive breast carcinoma with metastatic nodes from 1998 to 2008. We divided the study population into 4 groups: 1–3 positive nodes with/without chemotherapy and ≥4 positive nodes with/without chemotherapy. Risk factors for LRR were identified and the relationship between LRR and PMRT was analyzed.

Results

During the median follow-up of 59.6 months, 61 (7.7%) patients experienced LRR. In patients who received chemotherapy, independent LRR risk factors were high nuclear grade, severe lymphatic invasion, vascular invasion, and progesterone receptor-negative status in patients with 1–3 positive nodes, and severe lymphatic invasion and estrogen receptor-negative status in patients with ≥4 nodes. Although patients treated with PMRT had good outcomes, there was no significant difference, and PMRT did not significantly improve the outcome of the patients with all risk factors.

Conclusions

With systemic therapy and adequate dissection, PMRT by itself was of limited value in establishing locoregional control. The indication for PMRT in patients with 1–3 positive nodes remains controversial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Overgaad M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337:949–955

    Article  Google Scholar 

  2. Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956–962

    Article  PubMed  CAS  Google Scholar 

  3. Olson JE, Neuberg D, Pandya KJ et al (1997) The role of radiotherapy in the management of operative locally advanced breast cancer: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 79:1138–1149

    Article  PubMed  CAS  Google Scholar 

  4. Pierce LJ (2006) The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23:1706–1717

    Article  Google Scholar 

  5. Katz A, Strom EA, Buchholz TA et al (2001) The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 50:733–742

    Google Scholar 

  6. Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247–253

    Article  PubMed  Google Scholar 

  7. Truong PT, Olivotto IA, Whelan TJ et al (2004) Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170:1263–1273

    Article  PubMed  Google Scholar 

  8. Marks LB, Zeng J, Prosnitz LR (2008) One to three versus four or more positive nodes and postmastectomy radiotherapy: time to end the debate. J Clin Oncol 28:2075–2077

    Article  Google Scholar 

  9. Goldhirsch A, Glick JH, Gelber RD et al (1998) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601–1608

    Article  PubMed  CAS  Google Scholar 

  10. Goldhirsch A, Glick JH, Gelber RD et al (2001) Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19:3817–3827

    PubMed  CAS  Google Scholar 

  11. Goldhirsch A, Wood WC, Gelber RD et al (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21:3357–3365

    Google Scholar 

  12. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569–1583

    Article  PubMed  CAS  Google Scholar 

  13. Goldhirsch A, Wood WC, Gelber RD et al (2007) Progress and promise: highlights of international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133–1144

    Article  PubMed  CAS  Google Scholar 

  14. The World Health Organization (1983) The World Health Organization histological ty** of breast tumors second edition. Am J Clin Pathol 78:806–816

    Google Scholar 

  15. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histopathological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410

    Article  PubMed  CAS  Google Scholar 

  16. The Japanese Breast Cancer Society (2008) General rules for clinical and pathological recording of breast cancer, 16th edn. Kanehara, Tokyo (in Japanese)

    Google Scholar 

  17. Tsuda H, Akiyama F, Kurosumi M et al (1998) Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Jpn J Clin Oncol 28:486–491

    Article  PubMed  CAS  Google Scholar 

  18. Katz A, Strom EA, Buchholz TA et al (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implication for postoperative irradiation. J Clin Oncol 18:2817–2827

    PubMed  CAS  Google Scholar 

  19. Wallgren A, Bonetti RD, Gelber RD et al (2003) Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer study group trials I through VII. J Clin Oncol 21:1205–1213

    Article  PubMed  CAS  Google Scholar 

  20. Nielsen HM, Overgaard M, Grau C et al (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer-risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 79:147–155

    Article  PubMed  Google Scholar 

  21. Yildirum E (2009) Locoregional recurrence in breast carcinoma patients. Eur J Surg Oncol 35:258–265

    Article  Google Scholar 

  22. Taghian A, Jeong JH, Mamounas E et al (2004) Patterns of locoregional failure in patients with operative breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol 22:4247–4254

    Article  PubMed  Google Scholar 

  23. Kyndi M, Sørensen FB, Knudsen H et al (2009) Response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast cancer cooperate group. J Clin Oncol 26:1419–1426

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Breast Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Tomoya Nagao, Takayuki Kinoshita, Nobuko Tamura & Takashi Hojo

  2. Department of Therapeutic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Madoka Morota & Yoshikazu Kagami

Authors
  1. Tomoya Nagao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takayuki Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuko Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Hojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Madoka Morota
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshikazu Kagami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takayuki Kinoshita.

About this article

Cite this article

Nagao, T., Kinoshita, T., Tamura, N. et al. Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy. Int J Clin Oncol 18, 54–61 (2013). https://doi.org/10.1007/s10147-011-0343-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0343-y

Keywords

Search

Navigation